<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1682">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02156700</url>
  </required_header>
  <id_info>
    <org_study_id>KBD-IG1</org_study_id>
    <nct_id>NCT02156700</nct_id>
  </id_info>
  <brief_title>Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors</brief_title>
  <official_title>Quantitative Real-time Ultrasound Elastography (Shear Wave Elastography - SWE™) for Characterisation of Liver Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Dubrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Dubrava</source>
  <oversight_info>
    <authority>Croatia: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shear Wave Elastography (SWE™) is a quantitative elastography method for measuring tissue
      stiffness.  The difference in stiffness between benign and malignant tumors has been
      demonstrated by other elastography methods (acoustic radiation force impulse imaging,
      transient elastography and/or magnetic resonance elastography). The investigators
      hypothesized that benign liver tumors are softer than malignant liver tumors measured by
      SWE™, allowing differentiation between the two by tumor stiffness expressed in kilopascal
      (kPa). In this study benign and malignant liver tumors will be evaluated in three groups: 1)
      hemangiomas presenting the most common benign liver tumors; 2) metastases and
      cholangiocarcinomas presenting malignant tumors mostly appearing in otherwise healthy liver,
      and 3) hepatocellular carcinomas which will be evaluated separately because they occur
      mostly in cirrhotic liver which can potentially influence elastographic measurements
      therefore querying the appropriateness of comparison between tumors in healthy and cirrhotic
      liver. The nature of the liver tumor will be defined through a standard diagnostic workup
      according to current guidelines, including contrast enhanced multi-slice CT, MRI, and/or
      cytology/histology, as applicable. Enrolled patients will undergo transabdominal
      ultrasonography and SWE™ examination. The tumor stiffness will be measured five times for
      each tumor. Mean tumor stiffness for each group will be calculated as well as a cut-off
      value for the differentiation of benign and malignant tumors. The clinical value of the
      method will be appraised based on specificity, sensitivity, positive and negative predictive
      values.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Tumor stiffness</measure>
    <time_frame>at the time of enrollment</time_frame>
    <safety_issue>No</safety_issue>
    <description>tumor stiffness expressed in kPa, measured by ShearWave ™ Elastography (SWE™) Aixplorer® ultrasound machine from SuperSonic Imagine, Aix-en-Provence, France</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">159</enrollment>
  <condition>Haemangioma</condition>
  <condition>Metastases</condition>
  <condition>Cholangiocarcinoma</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>Liver tumors</arm_group_label>
    <description>Measurement of tumor stiffness by Shear wave elastography - SWE™</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Shear wave elastography</intervention_name>
    <description>Measurement of tumor stiffness by Shear wave elastography - SWE™</description>
    <arm_group_label>Liver tumors</arm_group_label>
    <other_name>Shear wave elastography - SWE™</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        outpatients and inpatients in a tertiary care hsopital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver tumors detected on US examination of the liver

          -  compliance to the study protocol

          -  signed approval for the diagnostic ultrasound with SWE™

        Exclusion Criteria:

          -  haemangioma, metastasis, cholangiocellular carcinoma (CCC) or hepatocellular
             carcinoma (HCC) in the proximity of liver capsule (less than 1 cm from the liver
             surface)

          -  haemangioma, metastasis, CCC or HCC deep in the lever parenchyma (more than 7 cm away
             from the surface)

          -  liver tumors other than haemangioma, metastasis, CCC and HCC

          -  severe hepatitis defined by alanine aminotransferase (ALT) values &gt; 5 x upper limit
             of normal (ULN)

          -  obstructive jaundice

          -  congestive heart failure

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivica Grgurevic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Dubrava Zagreb Croatia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ivica Grgurevic, MD, PhD</last_name>
    <email>ivica.grgurevic@zg.htnet.hr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tomislav Bokun, MD</last_name>
    <phone>00385981931020</phone>
    <email>tbokun@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Dubrava</name>
      <address>
        <city>Zagreb</city>
        <zip>10040</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomislav Bokun, MD</last_name>
      <phone>00385981931020</phone>
      <email>tbokun@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tomislav Bokun, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivica Grgurevic, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Masuzaki R, Tateishi R, Yoshida H, Sato T, Ohki T, Goto T, Yoshida H, Sato S, Sugioka Y, Ikeda H, Shiina S, Kawabe T, Omata M. Assessing liver tumor stiffness by transient elastography. Hepatol Int. 2007 Sep;1(3):394-7. doi: 10.1007/s12072-007-9012-7. Epub 2007 Jul 21. PubMed</citation>
    <PMID>19669335</PMID>
  </reference>
  <reference>
    <citation>Davies G, Koenen M. Acoustic radiation force impulse elastography in distinguishing hepatic haemangiomata from metastases: preliminary observations. Br J Radiol. 2011 Oct;84(1006):939-43. doi: 10.1259/bjr/97637841. Epub 2011 Mar 8. PubMed</citation>
    <PMID>21385910</PMID>
  </reference>
  <reference>
    <citation>Cho SH, Lee JY, Han JK, Choi BI. Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings. Ultrasound Med Biol. 2010 Feb;36(2):202-8. doi: 10.1016/j.ultrasmedbio.2009.10.009. Epub 2009 Dec 16. PubMed</citation>
    <PMID>20018432</PMID>
  </reference>
  <reference>
    <citation>Heide R, Strobel D, Bernatik T, Goertz RS. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry. Ultraschall Med. 2010 Aug;31(4):405-9. doi: 10.1055/s-0029-1245565. Epub 2010 Jul 22. PubMed</citation>
    <PMID>20652853</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 4, 2014</lastchanged_date>
  <firstreceived_date>May 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Dubrava</investigator_affiliation>
    <investigator_full_name>Ivica Grgurevic, MD</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>shear wave elastography</keyword>
  <keyword>haemangiomas</keyword>
  <keyword>metastases</keyword>
  <keyword>hepatocellular carcinoma</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
